Loading chat...
CT SB00025
Bill
Status
1/9/2017
Primary Sponsor
Insurance and Real Estate Committee
Click for details
AI Summary
-
Requires health carriers to issue immediate electronic authorization to pharmacies to dispense a temporary supply of prescribed drugs (excluding Schedule II and III controlled substances) when a covered person files a grievance or requests review of an adverse determination.
-
The temporary drug supply must be sufficient for the duration of the grievance or review process, with confirmation that payment will be available.
-
Health carriers must confirm with the prescribing provider within 24 hours of issuing authorization that the provider concurs with dispensing the temporary supply; if the provider does not concur, the carrier must cancel the authorization.
-
Exceptions apply to grievances or reviews concerning substitution of generic drugs or alternative brand name drugs for prescribed brand name drugs, unless the prescriber specified no substitution.
-
All provisions take effect January 1, 2018, and apply to adverse determination reviews under sections 38a-591d, 38a-591e, 38a-591f, and 38a-591g of Connecticut General Statutes.
Legislative Description
An Act Requiring Health Insurance Coverage Of A Prescribed Drug During Adverse Determination Reviews And External Review Processes.
Last Action
Referred to Joint Committee on Insurance and Real Estate
3/3/2017